MeVis Medical Solutions AG Logo
DE000A0LBFE4
A0LBFE
M3V.DE

MeVis Medical Solutions AG

Loading quotes...

Forecast

There is no analyst data available for this company.


  • MeVis Medical Solutions cuts full-year forecast after half-year results

    MeVis Medical Solutions reports first-half (1 Oct 2025–31 Mar 2026) revenues of TEUR 7,861 (prev. TEUR 8,438) and an EBIT of TEUR 160 (prev. TEUR 1,853). The decline is due to lower sales, higher personnel costs following the integration of the former joint venture MeVis Breast Care, weak demand in mammography and delays in lung-cancer screening in Germany. The outlook for 2025/2026 is adjusted to revenue of EUR 16.5m–17.0m and an expected EBIT of EUR 0.5m–1.0m (previous: revenue EUR 17.5–18.0m; EBIT EUR 1.0–1.5m). » More on de.investing.com


  • MeVis Medical Solutions AG revises 2024/2025 forecast downward

    MeVis Medical Solutions AG lowers its forecast for the 2024/2025 financial year and now expects revenue of EUR 16.5–17.0 million (previously EUR 17.0–17.5 million) and EBIT of EUR 3.0–3.5 million (previously EUR 3.5–4.0 million). The cause is a license sale that fell short of expectations and cannot be offset by maintenance and other revenues. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics
In 2026, MeVis Medical Solutions AG has already paid €0.95 in dividends. The last payout was in March.

Financials

In the last quarter, MeVis Medical Solutions AG had revenue of €3.93m and net profit of €311k
(EUR) March 2026
YoY
Revenue 3.93m -
Gross profit 599.77k -
Net profit 311k -
EBITDA 45.49k -

Fundamentals

Metric Value
Market capitalization
€36.76m
Number of shares
1.82m
52-week high/low
€26.80 - €19.90
Dividend yield
4.70%
Dividends TTM
€0.95
Beta
-0.04
P/E ratio
26.58
PEG ratio
-0.39
P/B ratio
2.06
P/S ratio
2.37

Company profile

MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological disorders. It offers X-ray modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, its services are used for technical visualization and online training. The company was founded in 1992 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG.

Name
MeVis Medical Solutions AG
CEO
Marcus Kirchhoff
Headquarters Bremen, be
Germany
Website
Sector
Information Technology
Industry
Software
IPO
16/11/2007
Employees 127

Ticker symbols

Exchange Symbol
XETRA
M3V.DE
Frankfurt
M3V.F
Düsseldorf
M3V.DU
London
0HI7.L
München
M3V.MU
Hamburg
M3V.HM
🍪

Parqet  uses cookies. Learn more